+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05051098

European Registry for Hepatitis B Virus Infection Supporting Future Immunotherapy Trials

Led by Hannover Medical School · Updated on 2026-10-05

3000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are establishing a European-wide registry to address the unmet needs in chronic hepatitis B virus HBV infection. This registry collects detailed information about patients with HBV mono- and co-infections to better understand virus and host-specific factors. The goal is to improve patient stratification for upcoming clinical trials, especially those investigating immunotherapies like therapeutic vaccines aimed at curing HBV infections. Participants in this observational study do not receive any interventions as part of the registry. A subgroup called the TherVacB sub-cohort consists of patients recruited under stricter criteria. This registry collects extensive data on viral and immune parameters over time to support future research and clinical trial design. During the study, participants provide data that researchers use to measure changes in hepatitis B surface antigen HBsAg levels, seroconversion rates, and various immune markers over five years. The study also tracks quality of life and liver-related health outcomes such as hepatocellular carcinoma, liver cirrhosis, and hepatitis B-related mortality. The overall study duration extends up to ten years, allowing long-term monitoring of these outcomes.

CONDITIONS

Brief Title

A Non-interventional Registry for Patients With Hepatitis B Virus Infection

Research Team

P

Petra Dörge

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here